Structural Studies of a Heavy Chain from a Mouse Immunoglobulin M with Antibody Activity
Elizabeth A. Robinson+2 more
openalex +1 more source
Organization of the diversity--joining region in rabbit immunoglobulin heavy chains as revealed by cleavage of a specific methionine residue in a100 allotype. [PDF]
Cécile Tonnelle+3 more
openalex +1 more source
Quantifying Protein–Glycan Interactions Using Native Mass Spectrometry
ABSTRACT Interactions between glycan‐binding proteins (GBPs) and carbohydrates (glycans) are essential to many biological processes relevant to human health and disease. For most GBPs, however, their glycan interactome—the repertoire of glycans recognized and their specificities—is poorly defined.
Duong T. Bui+4 more
wiley +1 more source
Association of Specific Gene Mutations with Immunoglobulin Heavy-Chain Variable Region and Chromosomal Alterations in Chronic Lymphocytic Leukemia Patients in India. [PDF]
Mani S, Nathany S, Diwan H, Mehta A.
europepmc +1 more source
Poorly Expressed Alleles of Several Human Immunoglobulin Heavy Chain Variable Genes are Common in the Human Population. [PDF]
Ohlin M.
europepmc +1 more source
Nanosensors in Leukemia Management: Pioneering Real‐Time Biomarker Detection for Precision Oncology
This review highlights pioneering nanosensors designed for real‐time leukemia biomarker detection, integrating advanced nanomaterials such as liposomes, polymeric nanoparticles and quantum dots. It examines electrochemical, optical and magnetic detection mechanisms, the applications across AML, ALL, CML, and CLL subtypes, and clinical translation ...
Hamed Soleimani Samarkhazan+5 more
wiley +1 more source
An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape. [PDF]
Deng W+12 more
europepmc +1 more source
Polymorphisms in human immunoglobulin heavy chain variable genes and their upstream regions. [PDF]
Mikocziova I+6 more
europepmc +1 more source
Abstract In recent years, targeted therapies have become the standard of care for refractory/relapsed mantle cell lymphoma (MCL). Although the mutational profile of MCL has been extensively studied, there is a lack of understanding of resistance mechanisms and genetic factors that impact the response to novel treatments.
Tamás László+19 more
wiley +1 more source